Canadians are ambivalent about a national pharmacare program, according to Department of Finance research. Focus groups polled by the department said any program should be income tested to serve only those who can’t afford out-of-pocket expenses for medication: ‘There were concerns about how much it might cost.’
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
